Show pageBacklinksCite current pageExport to PDFFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. Under the terms of the agreement announced October 19, 2000, shareholders of PercuSurge will receive .0802847 shares of Medtronic common stock for each share of PercuSurge they now hold. PercuSurge, a privately held company founded in 1995, now joins the Medtronic Vascular organization, which is headquartered in Santa Rosa, Calif. Gary Mistlin will lead the PercuSurge organization and will report to Andy Rasdal, president of Medtronic Vascular. Peter Rule will act as senior consultant to Rasdal on a variety of agreed-upon projects. PercuSurge has a number of products under development to treat complications arising from the release of embolic debris during interventional procedures. Its current product, the PercuSurge [[GuardWire]] Plus Temporary Occlusion and Aspiration system percusurge.txt Last modified: 2025/04/29 20:30by 127.0.0.1